AZIKAV IN COMPLEX TREATMENT OF HERPES ZOSTER

AZIKAV IN COMPLEX TREATMENT OF HERPES ZOSTER

Salimov B.M, Kasymov O.I, Munieva S.H.

AZIKAV IN COMPLEX TREATMENT OF HERPES ZOSTER

Department of Dermatology and STIs of the State Educational Establishment «Institute of Postgraduate Education in Health Sphere of Republic of Tajikistan»

Aim.A study of the effectiveness of atsikav (acyclovir) in the complex treatment of patients with herpes zoster.

Materials and methods. Under observation were 48 patients with herpes zoster. Among the patients with herpes zoster were 32 (66,2%) men and 16 (33,3%) women aged between 18 and 84 years. Methods: clinical, statistical.

Results. Treatment of patients has gone well. Side effects and complications of the drugs were not at any patient. The results showed the effectiveness of the treatment by complex therapy. So excellent results (clinical recovery) with typical form of herpes zoster in the end of the 1st week of observation in the complex therapy was achieved in 83.3% of patients and after 12-14 days in 100%. Among patients with bullous form of herpes zoster to the end of the 1st week of observation treatment has given excellent results in 80%. In hemorrhagic and generalized forms of herpes zoster to the end of the 1st week of treatment, a significant improvement was observed in 65% of patients and after 12-14 days in 80%. It should be noted that atsikav had no hepatotoxicity to any patient.

Conclusion. Patients with herpes zoster most frequently observed over the age of 60 years. More common at men. In winter, autumn and spring incidence is higher than in summer. Concomitant diseases were more common at older age groups. Atsikav antiviral drug can be recommended in the complex treatment of patients with herpes zoster.

  • Файлы:

Комментарии

Back to Top